Research and Development

The Research and Development team at Larimar Therapeutics is dedicated to advancing innovative therapies for complex rare diseases. Comprising scientists and clinical experts, the team focuses on the preclinical and clinical evaluation of their lead compound, CTI-1601, including conducting Phase 1 trials and ensuring regulatory compliance, while also exploring new research avenues to enhance treatment efficacy and patient outcomes.